The store will not work correctly when cookies are disabled.
2-(3,4-dimethoxyphenyl)-5-(2-(pyridazin-4-yl)-5-(trifluoromethoxy)phenyl)-1,3,4-oxadiazole
ID: ALA4556488
PubChem CID: 155556739
Max Phase: Preclinical
Molecular Formula: C21H15F3N4O4
Molecular Weight: 444.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2nnc(-c3cc(OC(F)(F)F)ccc3-c3ccnnc3)o2)cc1OC
Standard InChI: InChI=1S/C21H15F3N4O4/c1-29-17-6-3-12(9-18(17)30-2)19-27-28-20(31-19)16-10-14(32-21(22,23)24)4-5-15(16)13-7-8-25-26-11-13/h3-11H,1-2H3
Standard InChI Key: AFXYRPLAVTVMAK-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
12.6568 -13.2607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6556 -14.0803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3637 -14.4892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0734 -14.0798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0705 -13.2571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3619 -12.8519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3595 -12.0347 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0659 -11.6240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0635 -10.8068 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.7749 -12.0305 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.7714 -11.2096 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.7817 -14.4873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8689 -15.2974 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6685 -15.4661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0761 -14.7577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5282 -14.1514 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8927 -14.7548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3017 -15.4630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1177 -15.4605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5243 -14.7512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1091 -14.0431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2946 -14.0491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3415 -14.7473 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7535 -15.4530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5127 -13.3325 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.3299 -13.3268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3635 -15.3064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6559 -15.7121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6554 -16.5285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3635 -16.9381 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0737 -16.5253 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0707 -15.7102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
8 9 1 0
8 10 1 0
8 11 1 0
4 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
23 24 1 0
21 25 1 0
25 26 1 0
3 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 444.37 | Molecular Weight (Monoisotopic): 444.1045 | AlogP: 4.78 | #Rotatable Bonds: 6 |
Polar Surface Area: 92.39 | Molecular Species: NEUTRAL | HBA: 8 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.24 | CX LogP: 3.57 | CX LogD: 3.57 |
Aromatic Rings: 4 | Heavy Atoms: 32 | QED Weighted: 0.42 | Np Likeness Score: -0.67 |
References
1. Reed CW, Washecheck JP, Quitlag MC, Jenkins MT, Rodriguez AL, Engers DW, Blobaum AL, Conn PJ, Niswender CM, Lindsley CW.. (2019) Surveying heterocycles as amide bioisosteres within a series of mGlu7 NAMs: Discovery of VU6019278., 29 (10): [PMID:30910459] [10.1016/j.bmcl.2019.03.016] |